Prosolus Pharmaceuticals: ProSolus invests in manufacturing capacity for transdermal drug delivery tech

Mission Pharmacal subsidiary ProSolus Inc. said this week that it expanded its manufacturing capabilities and commercialization efforts for transdermal drug delivery technologies. The Miami-based company, which develops and manufactures transdermal and trans-mucosal drug delivery products, installed a 2nd transdermal production facility in Boerne, Texas. The new location has a larger production line than the Miami [...]The post ProSolus invests in manufacturing capacity for transdermal drug delivery tech appeared first on MassDevice.